Study: 26% of C. Diff Patients Received Only Unnecessary Antimicrobials
Infection Control and Hospital Epidemiology.
Researchers studied 246 patients with new-onset CDI diagnosed at Minneapolis Veterans Affairs Medical Center from January 2004 through December 2006. Two infectious disease physicians evaluated the use of non-CDI antimicrobials (those that are inactive against C. diff), which they defined as unnecessary if not fully indicated.
Data showed 57 percent of patients received non-CDI antimicrobials during and/or after their CDI treatment, and 77 percent received at least one unnecessary antimicrobial dose. Twenty-six percent of patients received only unnecessary antimicrobials.
More Articles on C. diff:Quidel Receives FDA Clearance for Handheld Molecular Diagnostic Test for C. Difficile
Illinois Publishes C. Diff, MRSA Data From Lab Tests for First Time
Study: Dog Correctly Detected C. Difficile in Patients
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
Medline's 10-day hand care challengeRead Now
- PGM Billing launches free ICD-10 code conversion tool
- DISC Sports & Spine Center to launch hip arthroscopy center of excellence: 4 things to know
- Researchers develop new chronic pain scoring system
- Pro-ASC EHR legislation heading to House of Representatives — 5 key updates
- GI physician leader to know: Dr. Glenn Eisen of The Oregon Clinic